Maturity-onset Diabetes of the Young
📧 Sign up to get email alerts when something new happens for Maturity-onset Diabetes of the Young.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: China Monogenic Diabetes Registry
This clinical trial registry entry outlines the China Monogenic Diabetes Registry, which is currently recruiting participants with neonatal …
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes [EARLY_Phase 1]
An early-phase study assessing whether insulin adjunctive therapy can reduce iatrogenic hyperinsulinemia in Type 1 Diabetes Mellitus and Mat…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) [Phase 2]
A Phase 2 clinical trial is evaluating liraglutide in patients with Maturity-onset diabetes of the young (MODY), currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Monogenic Diabetes Misdiagnosed as Type 1
The study, sponsored by McGill University Health Centre/Research Institute, is recruiting to investigate misdiagnosis of monogenic diabetes …
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)
This clinical trial update discusses the potential pathophysiological role of incretin hormones in maturity-onset diabetes of the young (MOD…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.